Category: AMDF Research News
-
With Gifts From Donors, AMDF Invests In Breakthrough Macular Degeneration Research
As we get ready to turn another year over, we’d like to pause and share a few of the standout highlights and breakthroughs that donor support, your support, helped achieve. In 2024, donor gifts were directed toward multiple research projects, and these investigations continue to evolve toward meaningful improvements in the lives of those affected…
-
Research Concludes Macular Degeneration is a Risk Factor for Severe Covid-19
Fairly early in the pandemic, we reported that AMD might be a risk factor for more severe COVID infections. Doctors had observed high rates of severe COVID-19 infections and death among hospitalized patients who had AMD, but the evidence was anecdotal. The most recent research, published by researchers at Boston University Chobanian & Avedisian School of…
-
Study Indicates AMD Patients are at Higher Risk of COVID-19 Complications
A study conducted at New York Presbyterian/Columbia University Irving Medical Center, and published in Nature Medicine, indicates that patients with macular degeneration are at higher risk of complications due to COVID-19. The study, entitled “Immune complement and coagulation dysfunction in adverse outcomes of SARS-CoV-2 infection,” looked at 6,398 COVID patients during the first wave of…
-
Cutting Edge Research Grants Announced by The American Macular Degeneration Foundation, Co-funded with Research to Prevent Blindness
The American Macular Degeneration Foundation (AMDF), in partnership with Research to Prevent Blindness (RPB), has announced the recipients of the RPB/AMDF Catalyst Awards for Innovative Research Approaches for Age-Related Macular Degeneration, which provide seed money for high-risk/high-gain AMD research into both dry and wet forms of the disease. Each grantee will receive $300,000, payable across…
-
AMDF In the Trenches: Stimulating Research Through New Grants and Partnerships
Through a growing portfolio of research grants and creative partnerships with other eye research funders, the American Macular Degeneration Foundation (AMDF) is finding ways to efficiently leverage its resources and accelerate the development of promising approaches to improve the lives of age-related macular degeneration (AMD) patients. At AMDF, we have been hearing from researchers that…
-
AMDF Supported Researcher Receives Award at ARVO 2017
Back in May, some members of our team attended the ARVO 2017 conference in Baltimore, MD. ARVO is The Association for Research in Vision and Ophthalmology and is the largest eye and vision research organization in the world, and the yearly conference is the largest gathering of those researchers and doctors. Our mission in attending…
-
AMDF Featured in The Harvard Medical School of Ophthalmology
The Harvard Medical School of Opthalmology featured AMDF in their April 2014 EyeWitness newsletter
-
AMDF Featured in The New York Times
Sane Steps May Save Your Precious Central Vision The AMDF has been featured in the New York Times.Below is a reprint of the article. By JANE E. BRODY Dr. Sidney Schreiber, a cardiologist from Scarsdale, N.Y., was in his mid-70’s and still working in the lab and caring for patients when he noticed that he…